BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 31019093)

  • 1. Partial inhibition of the overactivated Ku80-dependent DNA repair pathway rescues neurodegeneration in
    Lopez-Gonzalez R; Yang D; Pribadi M; Kim TS; Krishnan G; Choi SY; Lee S; Coppola G; Gao FB
    Proc Natl Acad Sci U S A; 2019 May; 116(19):9628-9633. PubMed ID: 31019093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription elongation factor AFF2/FMR2 regulates expression of expanded GGGGCC repeat-containing C9ORF72 allele in ALS/FTD.
    Yuva-Aydemir Y; Almeida S; Krishnan G; Gendron TF; Gao FB
    Nat Commun; 2019 Nov; 10(1):5466. PubMed ID: 31784536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into C9ORF72-Related ALS/FTD from Drosophila and iPSC Models.
    Yuva-Aydemir Y; Almeida S; Gao FB
    Trends Neurosci; 2018 Jul; 41(7):457-469. PubMed ID: 29729808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of Hsp90 and the antimicrobial peptide Mtk suppresses poly(GR)-induced neurotoxicity in C9ORF72-ALS/FTD.
    Lee S; Jun YW; Linares GR; Butler B; Yuva-Adyemir Y; Moore J; Krishnan G; Ruiz-Juarez B; Santana M; Pons M; Silverman N; Weng Z; Ichida JK; Gao FB
    Neuron; 2023 May; 111(9):1381-1390.e6. PubMed ID: 36931278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZNF598 co-translationally titrates poly(GR) protein implicated in the pathogenesis of C9ORF72-associated ALS/FTD.
    Park J; Lee J; Kim JH; Lee J; Park H; Lim C
    Nucleic Acids Res; 2021 Nov; 49(19):11294-11311. PubMed ID: 34551427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis.
    Farg MA; Konopka A; Soo KY; Ito D; Atkin JD
    Hum Mol Genet; 2017 Aug; 26(15):2882-2896. PubMed ID: 28481984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(GR) in C9ORF72-Related ALS/FTD Compromises Mitochondrial Function and Increases Oxidative Stress and DNA Damage in iPSC-Derived Motor Neurons.
    Lopez-Gonzalez R; Lu Y; Gendron TF; Karydas A; Tran H; Yang D; Petrucelli L; Miller BL; Almeida S; Gao FB
    Neuron; 2016 Oct; 92(2):383-391. PubMed ID: 27720481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9 screen in human iPSC-derived cortical neurons identifies NEK6 as a novel disease modifier of C9orf72 poly(PR) toxicity.
    Guo W; Wang H; Kumar Tharkeshwar A; Couthouis J; Braems E; Masrori P; Van Schoor E; Fan Y; Ahuja K; Moisse M; Jacquemyn M; Furtado Madeiro da Costa R; Gajjar M; Balusu S; Tricot T; Fumagalli L; Hersmus N; Janky R; Impens F; Vanden Berghe P; Ho R; Thal DR; Vandenberghe R; Hegde ML; Chandran S; De Strooper B; Daelemans D; Van Damme P; Van Den Bosch L; Verfaillie C
    Alzheimers Dement; 2023 Apr; 19(4):1245-1259. PubMed ID: 35993441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas9 Screens Identify the RNA Helicase DDX3X as a Repressor of C9ORF72 (GGGGCC)n Repeat-Associated Non-AUG Translation.
    Cheng W; Wang S; Zhang Z; Morgens DW; Hayes LR; Lee S; Portz B; Xie Y; Nguyen BV; Haney MS; Yan S; Dong D; Coyne AN; Yang J; Xian F; Cleveland DW; Qiu Z; Rothstein JD; Shorter J; Gao FB; Bassik MC; Sun S
    Neuron; 2019 Dec; 104(5):885-898.e8. PubMed ID: 31587919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptide repeat proteins inhibit homology-directed DNA double strand break repair in C9ORF72 ALS/FTD.
    Andrade NS; Ramic M; Esanov R; Liu W; Rybin MJ; Gaidosh G; Abdallah A; Del'Olio S; Huff TC; Chee NT; Anatha S; Gendron TF; Wahlestedt C; Zhang Y; Benatar M; Mueller C; Zeier Z
    Mol Neurodegener; 2020 Feb; 15(1):13. PubMed ID: 32093728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9-mediated excision of ALS/FTD-causing hexanucleotide repeat expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro.
    Meijboom KE; Abdallah A; Fordham NP; Nagase H; Rodriguez T; Kraus C; Gendron TF; Krishnan G; Esanov R; Andrade NS; Rybin MJ; Ramic M; Stephens ZD; Edraki A; Blackwood MT; Kahriman A; Henninger N; Kocher JA; Benatar M; Brodsky MH; Petrucelli L; Gao FB; Sontheimer EJ; Brown RH; Zeier Z; Mueller C
    Nat Commun; 2022 Oct; 13(1):6286. PubMed ID: 36271076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Senataxin helicase, the causal gene defect in ALS4, is a significant modifier of C9orf72 ALS G4C2 and arginine-containing dipeptide repeat toxicity.
    Bennett CL; Dastidar S; Arnold FJ; McKinstry SU; Stockford C; Freibaum BD; Sopher BL; Wu M; Seidner G; Joiner W; Taylor JP; West RJH; La Spada AR
    Acta Neuropathol Commun; 2023 Oct; 11(1):164. PubMed ID: 37845749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3.
    Ramesh N; Daley EL; Gleixner AM; Mann JR; Kour S; Mawrie D; Anderson EN; Kofler J; Donnelly CJ; Kiskinis E; Pandey UB
    Acta Neuropathol Commun; 2020 Oct; 8(1):177. PubMed ID: 33129345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality-control mechanisms targeting translationally stalled and C-terminally extended poly(GR) associated with ALS/FTD.
    Li S; Wu Z; Tantray I; Li Y; Chen S; Dong J; Glynn S; Vogel H; Snyder M; Lu B
    Proc Natl Acad Sci U S A; 2020 Oct; 117(40):25104-25115. PubMed ID: 32958650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UBQLN2-HSP70 axis reduces poly-Gly-Ala aggregates and alleviates behavioral defects in the C9ORF72 animal model.
    Zhang K; Wang A; Zhong K; Qi S; Wei C; Shu X; Tu WY; Xu W; Xia C; Xiao Y; Chen A; Bai L; Zhang J; Luo B; Wang W; Shen C
    Neuron; 2021 Jun; 109(12):1949-1962.e6. PubMed ID: 33991504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced insulin signalling ameliorates C9orf72 hexanucleotide repeat expansion toxicity in
    Atilano ML; Grönke S; Niccoli T; Kempthorne L; Hahn O; Morón-Oset J; Hendrich O; Dyson M; Adams ML; Hull A; Salcher-Konrad MT; Monaghan A; Bictash M; Glaria I; Isaacs AM; Partridge L
    Elife; 2021 Mar; 10():. PubMed ID: 33739284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS/FTD.
    Krishnan G; Raitcheva D; Bartlett D; Prudencio M; McKenna-Yasek DM; Douthwright C; Oskarsson BE; Ladha S; King OD; Barmada SJ; Miller TM; Bowser R; Watts JK; Petrucelli L; Brown RH; Kankel MW; Gao FB
    Nat Commun; 2022 May; 13(1):2799. PubMed ID: 35589711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Jun N-Terminal Kinase Promotes Stress Granule Assembly and Neurodegeneration in C9orf72-Mediated ALS and FTD.
    Sahana TG; Chase KJ; Liu F; Lloyd TE; Rossoll W; Zhang K
    J Neurosci; 2023 Apr; 43(17):3186-3197. PubMed ID: 37015810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammasome-Mediated Neuronal-Microglial Crosstalk: a Therapeutic Substrate for the Familial C9orf72 Variant of Frontotemporal Dementia/Amyotrophic Lateral Sclerosis.
    Trageser KJ; Yang EJ; Smith C; Iban-Arias R; Oguchi T; Sebastian-Valverde M; Iqbal UH; Wu H; Estill M; Al Rahim M; Raval U; Herman FJ; Zhang YJ; Petrucelli L; Pasinetti GM
    Mol Neurobiol; 2023 Jul; 60(7):4004-4016. PubMed ID: 37010807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody Therapy Targeting RAN Proteins Rescues C9 ALS/FTD Phenotypes in C9orf72 Mouse Model.
    Nguyen L; Montrasio F; Pattamatta A; Tusi SK; Bardhi O; Meyer KD; Hayes L; Nakamura K; Banez-Coronel M; Coyne A; Guo S; Laboissonniere LA; Gu Y; Narayanan S; Smith B; Nitsch RM; Kankel MW; Rushe M; Rothstein J; Zu T; Grimm J; Ranum LPW
    Neuron; 2020 Feb; 105(4):645-662.e11. PubMed ID: 31831332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.